Marius Ilié

9.6k total citations · 1 hit paper
165 papers, 5.9k citations indexed

About

Marius Ilié is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Marius Ilié has authored 165 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Oncology, 84 papers in Pulmonary and Respiratory Medicine and 61 papers in Cancer Research. Recurrent topics in Marius Ilié's work include Lung Cancer Treatments and Mutations (67 papers), Cancer Genomics and Diagnostics (46 papers) and Cancer Immunotherapy and Biomarkers (37 papers). Marius Ilié is often cited by papers focused on Lung Cancer Treatments and Mutations (67 papers), Cancer Genomics and Diagnostics (46 papers) and Cancer Immunotherapy and Biomarkers (37 papers). Marius Ilié collaborates with scholars based in France, United States and Germany. Marius Ilié's co-authors include Paul Hofman, Véronique Hofman, Élodie Long-Mira, Jérôme Mouroux, Charles‐Hugo Marquette, Éric Selva, Catherine Butori, Christelle Bonnetaud, Nicolas Vénissac and Sandra Lassalle and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Marius Ilié

156 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategies

2015 459 citations Marius Ilié, Élodie Long-Mira et al. profile →

Peers

Countries citing papers authored by Marius Ilié

Since Specialization

Citations

This map shows the geographic impact of Marius Ilié's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marius Ilié with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marius Ilié more than expected).

Fields of papers citing papers by Marius Ilié

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marius Ilié. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marius Ilié. The network helps show where Marius Ilié may publish in the future.

Co-authorship network of co-authors of Marius Ilié

This figure shows the co-authorship network connecting the top 25 collaborators of Marius Ilié. A scholar is included among the top collaborators of Marius Ilié based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marius Ilié. Marius Ilié is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Reproducibility of c-Met Immunohistochemical Scoring (Clone SP44) for Non–Small Cell Lung Cancer Using Conventional Light Microscopy and Whole Slide Imaging 2024 ·The American Journal of Surgical Pathology ·(unknown), Véronique Hofman, Emmanuel Chamorey, Renaud Schiappa, Sandra Lassalle, Élodie Long-Mira, Katia Zahaf, Salomé Lalvée, (unknown), Christelle Bonnetaud, (unknown), Marius Ilié, Paul Hofman	1
2	Shifting from Immunohistochemistry to Screen for ALK Rearrangements: Real-World Experience in a Large Single-Center Cohort of Patients with Non-Small-Cell Lung Cancer 2024 ·Cancers ·Marius Ilié, (unknown), (unknown), (unknown), Salomé Lalvée, Olivier Bordone, Katia Zahaf, Christelle Bonnetaud, Kevin Washetine, Sandra Lassalle, Élodie Long-Mira, Simon Heeke, Véronique Hofman, Paul Hofman	5
3	Navigating Change in Tumor Naming: Exploring the Complexities and Considerations of Shifting Toward Molecular Classifications 2024 ·Journal of Clinical Oncology ·Marius Ilié, Simon Heeke, Denis Horgan, Paul Hofman	3
4	Molecular Profiling in Non-Squamous Non-Small Cell Lung Carcinoma: Towards a Switch to Next-Generation Sequencing Reflex Testing 2022 ·Journal of Personalized Medicine ·(unknown), Simon Heeke, (unknown), Jacques Boutros, Marius Ilié, Véronique Hofman, Charles‐Hugo Marquette, Paul Hofman, Jonathan Benzaquen	10
5	Deep Learning Facilitates Distinguishing Histologic Subtypes of Pulmonary Neuroendocrine Tumors on Digital Whole-Slide Images 2022 ·Cancers ·Marius Ilié, Jonathan Benzaquen, (unknown), Simon Heeke, Nicholas Ayache, Hervé Delingette, Élodie Long-Mira, Sandra Lassalle, (unknown), (unknown), Josiane Otto, Charlotte Cohen, (unknown), Jean‐Philippe Berthet, Charles‐Hugo Marquette, Véronique Hofman, (unknown), Paul Hofman	11
6	Fusion‐positive non‐small cell lung carcinoma: Biological principles, clinical practice, and diagnostic implications 2022 ·Genes Chromosomes and Cancer ·Daniel Kazdal, Véronique Hofman, Petros Christopoulos, Marius Ilié, Albrecht Stenzinger, Paul Hofman	38
7	Two Patients With Advanced-Stage Lung Adenocarcinoma With Radiologic Complete Response to Nivolumab Treatment Harboring an STK11/LKB1 Mutation 2020 ·JCO Precision Oncology ·Ernest Nadal, Simon Heeke, Jonathan Benzaquen, Noelia Vilariño, Arturo Navarro-Martín, Daniel Azuara, Mar Varela, Josiane Otto, Núria Baixeras, David Shahbazian, Pascal Puchois, S. Church, Thomas H. Smith, (unknown), Marius Ilié, Paul Hofman	11
8	Comparison of Three Sequencing Panels Used for the Assessment of Tumor Mutational Burden in NSCLC Reveals Low Comparability 2020 ·Journal of Thoracic Oncology ·Simon Heeke, Jonathan Benzaquen, Véronique Hofman, Élodie Long-Mira, (unknown), Olivier Bordone, Charles‐Hugo Marquette, Hervé Delingette, Marius Ilié, Paul Hofman	14
9	Targeted Assessment of the EGFR Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France) 2020 ·Cancers ·Sandra Lassalle, Véronique Hofman, Simon Heeke, Jonathan Benzaquen, Élodie Long-Mira, M. Poudenx, (unknown), Jacques Boutros, Virginie Tanga, Katia Zahaf, Salomé Lalvée, (unknown), Olivier Bordone, (unknown), Christelle Bonnetaud, Charles‐Hugo Marquette, Marius Ilié, Paul Hofman	17
10	Multiplexed Immunohistochemistry for Molecular and Immune Profiling in Lung Cancer—Just About Ready for Prime-Time? 2019 ·Cancers ·Paul Hofman, Cécile Badoual, (unknown), Léa Berland, (unknown), Élodie Long-Mira, Sandra Lassalle, Hélène Roussel, Véronique Hofman, Éric Tartour, Marius Ilié	78
11	Circulating Tumor Cell Detection in Lung Cancer: But to What End? 2019 ·Cancers ·Véronique Hofman, Simon Heeke, Charles‐Hugo Marquette, Marius Ilié, Paul Hofman	19
12	Matrix Stiffening and EGFR Cooperate to Promote the Collective Invasion of Cancer Cells 2018 ·Cancer Research ·Eloïse M. Grasset, Thomas Bertero, Alexandre Bozec, (unknown), Isabelle Bourget, Sabrina Pisano, (unknown), Majdi Maiel, Caroline Bailleux, Alexander Emelyanov, Marius Ilié, Paul Hofman, Guerrino Meneguzzi, Christophe Duranton, Dmitry V. Bulavin, Cédric Gaggioli	82
13	Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients? 2018 ·Cancers ·Véronique Hofman, Sandra Lassalle, Coraline Bence, Élodie Long-Mira, Sacha Nahon‐Estève, Simon Heeke, (unknown), Catherine Butori, Marius Ilié, Paul Hofman	16
14	Rapid decay of engulfed extracellular miRNA by XRN1 exonuclease promotes transient epithelial-mesenchymal transition 2016 ·Nucleic Acids Research ·Joséphine Zangari, Marius Ilié, Florian Rouaud, (unknown), Mickaël Ohanna, (unknown), (unknown), (unknown), Nicolas Nottet, Cathy Staedel, Jocelyn Gal, Bernard Mari, Baharia Mograbi, Paul Hofman, Patrick Brest	32
15	Genetic and Pharmacological Inactivation of the Purinergic P2RX7 Receptor Dampens Inflammation but Increases Tumor Incidence in a Mouse Model of Colitis-Associated Cancer 2015 ·Cancer Research ·Paul Hofman, Julien Cherfils‐Vicini, (unknown), Marius Ilié, Thierry Juhel, Xavier Hébuterne, Éric Gilson, Annie Schmid‐Alliana, Olivier Boyer, Sahil Adriouch, Valérie Vouret‐Craviari	96
16	Autophagy Plays a Critical Role in the Degradation of Active RHOA, the Control of Cell Cytokinesis, and Genomic Stability 2013 ·Cancer Research ·Amine Belaïd, Michaël Cerezo, Abderrahman Chargui, Elisabeth Corcelle–Termeau, Florence Pédeutour, Sandy Giuliano, Marius Ilié, Isabelle Rubera, Michel Tauc, (unknown), Corine Bertolotto, Patrick Brest, Valérie Vouret‐Craviari, Daniel J. Klionsky, Georges F. Carle, Paul Hofman, Baharia Mograbi	78
17	Expression of a Truncated Active Form of VDAC1 in Lung Cancer Associates with Hypoxic Cell Survival and Correlates with Progression to Chemotherapy Resistance 2012 ·Cancer Research ·M. Christiane Brahimi-Horn, Danya Ben-Hail, Marius Ilié, Pierre Gounon, Matthieu Rouleau, Véronique Hofman, J. Doyen, Bernard Mari, Varda Shoshan‐Barmatz, Paul Hofman, Jacques Pouysségur, Nathalie M. Mazure	64
18	Cadmium-Induced Autophagy in Rat Kidney: An Early Biomarker of Subtoxic Exposure 2011 ·Toxicological Sciences ·Abderrahman Chargui, S. Zekri, Grégory Jacquillet, Isabelle Rubera, Marius Ilié, Amine Belaïd, Christophe Duranton, Michel Tauc, Paul Hofman, Philippe Poujeol, Michèle Véronique El May, Baharia Mograbi	122
19	Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland? 2011 ·Endocrine Related Cancer ·Sandra Lassalle, Véronique Hofman, Marius Ilié, Christelle Bonnetaud, Marie-Pierre Puisségur, Patrick Brest, (unknown), N. Guevara, Olivier Bordone, Bruno Cardinaud, Kévin Lebrigand, Géraldine Rios, (unknown), Brigitte Franc, Bernard Mari, Abir Al Ghuzlan, Philippe Vielh, Pascal Barbry, Paul Hofman	28
20	Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker 2010 ·Clinical Cancer Research ·Véronique Hofman, Christelle Bonnetaud, Marius Ilié, Philippe Vielh, J Vignaud, Jean François Fléjou, Sylvie Lantuéjoul, Éric Piaton, (unknown), Catherine Butori, Éric Selva, M. Poudenx, Stéphanie Sibon, (unknown), Nicolas Vénissac, Jean-Philippe Jaı̈s, Jérôme Mouroux, Thierry Jo Molina, Paul Hofman	247

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact